OpenLegislation

Paragraph 6 Exceptions – human or veterinary medicines or immunomodulatory approaches

Original text. Later amendments are not shown.

(1)

Exceptions to the activities described in paragraph 2 are the ownership, ownership of intellectual property or development of the matters set out in sub-paragraph (2) that employ synthetic biology at any stage of the development or production, unless the circumstances set out in sub-paragraph (3) apply.

(2)

The matters referred to in sub-paragraph (1) are—

(a)

human or veterinary medicines;

(b)

immunomodulatory approaches.

(3)

The circumstances referred to in sub-paragraph (1) are where the matter described in sub-paragraph (2)—

(a)

has a synthetic biology technology that could be employed or modified to produce, deliver or produce and deliver—

(i)

toxic chemicals to achieve an incapacitating or lethal effect on humans or animals;

(ii)

materials restricted under Schedule 5 to the Anti-terrorism, Crime and Security Act 2001f1; or

(b)

uses substances or pathogens set out in Schedule 5 to the Anti-terrorism, Crime and Security Act 2001.

Annotations

Footnotes

f1

Schedule 5 was amended by S.I. 2007/929 and 2012/1466.